SCHEMBL14047243

SCHEMBL14047243

O=C(Cc1ccc(-c2ccc(OCCN3CCNCC3)cc2F)nc1)NCc1nccc(F)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 4/20 0.42
CYP3A4 P08684 2/20 0.40
ROCK2 O75116 1/20 0.38
CTSC P53634 1/20 0.38
SRC P12931 2/20 0.37
ITGB3 P05106 4/20 0.37
ITGA2B P08514 4/20 0.37
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
ULK1 O75385 1/20 0.36
CCNA2 P20248 1/20 0.36
CDK2 P24941 1/20 0.36
CCNA1 P78396 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
SYK P43405 1/20 0.35
LTA4H P09960 1/20 0.35
AVPR1B P47901 1/20 0.35
ABL1 P00519 1/20 0.35
TUBB4A P04350 1/20 0.35
TUBB P07437 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19291990 0.92 ROCK1 (0.43) ROCK1CYP3A4ROCK2CTSCSRC
SCHEMBL254410 0.92 ROCK1 (0.41) ROCK1CYP3A4SRCKDM4EALDH1A1
SCHEMBL19291933 0.91 ROCK1 (0.41) ROCK1CYP3A4ROCK2CTSCSRC
SCHEMBL19291986 0.90 ROCK1 (0.43) ROCK1CYP3A4ROCK2CTSCSRC
SCHEMBL19291985 0.88 ROCK1 (0.43) ROCK1CYP3A4ROCK2SRCITGB3
SCHEMBL12782558 0.85 ROCK1 (0.40) ROCK1CYP3A4SRCKDM4EALDH1A1
SCHEMBL19291988 0.85 ROCK1 (0.45) ROCK1CYP3A4ROCK2CTSCSRC
SCHEMBL19291997 0.85 SRC (0.54) ROCK1CYP3A4ROCK2SRCITGB3
SCHEMBL254932 0.83 ROCK1 (0.43) ROCK1CYP3A4SRCKDM4EALDH1A1
SCHEMBL19291940 0.83 SRC (0.43) ROCK1CYP3A4ROCK2CTSCSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558085-B1 COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CANCER ATHENEX INC (US) 2017-08-30 EP disclosed
WO-2008127728-A1 BIARYL COMPOSITIONS AND METHODS FOR MODULATING A KINASE CASCADE KINEX PHARMACEUTICALS, LLC (US) 2008-10-23 WO disclosed